Post-Marketing Withdrawal Of Medicines Because of Adverse Drug Reactions: An Analysis of Anti-Obesity Medications

被引：0
|
作者：
Onakpoya, I. [1 ]
Heneghan, C. [1 ]
Aronson, J. [1 ]
机构：
[1] Univ Oxford, Primary Care Hlth Sci, Oxford, England
来源：
DRUG SAFETY | 2015年 / 38卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
P 127
引用
收藏
页码：1016 / 1017
页数：2
相关论文
共 50 条
  • [1] Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review
    Igho J. Onakpoya
    Carl J. Heneghan
    Jeffrey K. Aronson
    BMC Medicine, 14
  • [2] Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review
    Onakpoya, Igho J.
    Heneghan, Carl J.
    Aronson, Jeffrey K.
    BMC MEDICINE, 2016, 14
  • [3] Post-marketing withdrawal of analgesic medications because of adverse drug reactions: a systematic review
    Onakpoya, Igho J.
    Heneghan, Carl J.
    Aronson, Jeffrey K.
    EXPERT OPINION ON DRUG SAFETY, 2018, 17 (01) : 63 - 72
  • [4] Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature
    Igho J. Onakpoya
    Carl J. Heneghan
    Jeffrey K. Aronson
    BMC Medicine, 14
  • [5] Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature
    Onakpoya, Igho J.
    Heneghan, Carl J.
    Aronson, Jeffrey K.
    BMC MEDICINE, 2016, 14
  • [6] POST-MARKETING SURVEILLANCE OF ADVERSE REACTIONS TO NEW MEDICINES
    WILSON, AB
    BRITISH MEDICAL JOURNAL, 1977, 2 (6093): : 1001 - 1003
  • [7] Correction to: Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature
    Igho J. Onakpoya
    Carl J. Heneghan
    Jeffrey K. Aronson
    BMC Medicine, 17
  • [8] POST-APPROVAL WITHDRAWAL OF MEDICINES BECAUSE OF ADVERSE DRUG REACTIONS: A SYSTEMATIC REVIEW
    Onakpoya, I. J.
    Heneghan, C. J.
    Aronson, J. K.
    CLINICAL THERAPEUTICS, 2015, 37 (08) : E30 - E30
  • [9] Post-marketing surveillance and adverse drug reactions
    Shani, S
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 1999, 1 (02): : 117 - 119
  • [10] Withdrawal of anti-obesity medicines reviewed
    Reactions Weekly, 2016, 1631 (1) : 12 - 12
12345